Detalhe da pesquisa
1.
Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.
Int J Mol Sci
; 22(9)2021 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34062940
2.
Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer's Disease.
Int J Mol Sci
; 22(21)2021 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34769380
3.
PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment.
Prog Neurobiol
; 191: 101818, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32380223
4.
Glucocerebrosidase expression patterns in the non-human primate brain.
Brain Struct Funct
; 223(1): 343-355, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28835999
5.
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.
Neurotherapeutics
; 15(4): 1063-1081, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29987762
6.
Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System.
Front Neuroanat
; 11: 2, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28239341
7.
Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
Brain Struct Funct
; 222(4): 1767-1784, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27612857
8.
Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques.
Front Neuroanat
; 8: 146, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25520629